Clinical management of metastatic breast cancer.
The physician treating the patient with recurrent or metastatic breast cancer has a number of available therapeutic options. Various clinical and laboratory factors play a role in the decision process for the choice of the initial and subsequent treatments for such patients. The strategies for palliative therapy are reviewed along with estimates of potential benefits of the various modalities.
D000315:Adrenalectomy; D000328:Adult; D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D002369:Castration; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007016:Hypophysectomy; D008593:Menopause; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D010166:Palliative Care; D013997:Time Factors
D000477:Alkylating Agents; D000970:Antineoplastic Agents